In the Boardroom - Chile

Filter

Current filters:

Chile

Popular Filters

28 to 52 of 100 results

Report: Senior life sciences executives are going dark on social media

Report: Senior life sciences executives are going dark on social media

03-03-2014

Executives are moving back to an ‘ex-directory’ world, where smaller, restricted networks are of…

BiotechnologyBoardroom

Phosphagenics appoints three new non-executive directors

03-03-2014

Australian biotechnology firm Phosphagenics has appointed biotech industry veterans Lawrence Gozlan,…

AlchemiaAustraliaBiotechnologyBoardroomOxymorphonePhosphagenics

UCB CEO succession plan ahead of next wave of product launches

UCB CEO succession plan ahead of next wave of product launches

21-02-2014

Belgium’s largest drugmaker, UCB, yesterday announced a succession plan for its chief excecutive, Roch…

BoardroomManagementPharmaceuticalUCB

Merck names Simon Sturge as new head of biosimilars unit

Merck names Simon Sturge as new head of biosimilars unit

20-02-2014

Germany’s Merck KGaA has appointed Simon Sturge to head the biosimilars unit, effective March 1, succeeding…

BiosimilarsBiotechnologyBoardroomManagementMerck KGaA

Avillion appoints CMO Allison Jeynes-Ellis as chief executive

Avillion appoints CMO Allison Jeynes-Ellis as chief executive

18-02-2014

UK-based drug development company Avillion LLP has appointed Allison Jeynes-Ellis as chief executive.

BoardroombosutinibPharmaceuticalUK

Inovio announces new additions to senior management team

Inovio announces new additions to senior management team

18-02-2014

US drug developer Inovio Pharmaceuticals has expanded its senior management team with two appointments…

BoardroomImmunologicalsInovio PharmaceuticalsPharmaceuticalUSA

William Young to retire from Biogen’s board of directors after 17 years

William Young to retire from Biogen’s board of directors after 17 years

17-02-2014

US biotech firm Biogen Idec has announced today that chairman of the board William Young, known as Bill,…

Biogen IdecBoardroomPharmaceuticalUSA

Shire CFO Graham Hetherington to step down

Shire CFO Graham Hetherington to step down

13-02-2014

Ireland-headquartered drugmaker Shire (LSE: SHP) has announced that Graham Hetherington, chief financial…

BoardroomNorthern EuropePharmaceuticalShire

Exelixis appoints Jeffrey Hessekiel as Executive Vice President and General Counsel

Exelixis appoints Jeffrey Hessekiel as Executive Vice President and General Counsel

13-02-2014

Exelixis (NASDAQ: EXEL) have announced the appointment of Jeffrey Hessekiel as executive vice president…

BiotechnologyBoardroomExelixisOncologyUSA

Increasing investment in Latin American pharma market

Increasing investment in Latin American pharma market

12-02-2014

Around $12.7 billion has been invested in Latin America’s pharmaceutical market through mergers and…

ArgentinaBrazilChileEcuadorFinancialMergers & AcquisitionsPharmaceuticalSouth America

Immigration quotas could have knock-on effect on pharma industry recruitment

Immigration quotas could have knock-on effect on pharma industry recruitment

11-02-2014

European quotas for immigration could have an effect on the pharmaceutical industry, according to recruitment…

BoardroomManagementNorthern EuropePharmaceutical

Alchemia announces appointment of Santo Costa as chairman

Alchemia announces appointment of Santo Costa as chairman

11-02-2014

Australia-based biotech company Alchemia has announced the appointment of Santo Costa as non-executive…

AlchemiaAustraliaBiotechnologyBoardroom

Survey: Pharma CEOs on the importance of technology, demographics and innovation

Survey: Pharma CEOs on the importance of technology, demographics and innovation

07-02-2014

A global survey of chief executives has revealed the priorities and concerns of pharmaceutical and life…

BiotechnologyBoardroomGlobalMarkets & MarketingPharmaceutical

Leadership changes at NZ’s largest drugmaker Douglas Pharmaceuticals

Leadership changes at NZ’s largest drugmaker Douglas Pharmaceuticals

04-02-2014

The founder of Douglas Pharmaceuticals, Sir Graeme Douglas, has announced his retirement as the company’s…

BoardroomDouglas PharmaceuticalsManagementPharmaceutical

Actavis refocuses global business structure; reiterates 2014 outlook

Actavis refocuses global business structure; reiterates 2014 outlook

01-02-2014

US generics major Actavis, which now has its headquarters in Ireland, has announced a realignment of…

ActavisBoardroomFinancialGenerics

Merck KGaA names new board members

Merck KGaA names new board members

28-01-2014

E. Merck KG, which combines the financial interests of the Merck family and is general partner of Germany’s…

BoardroomGermanyMerck KGaAPharmaceutical

Karolinska Development names Christian Tange to succeed Robin Wright

28-01-2014

Karolinska Development has announced that Christian Tange has accepted the role of Chief Financial Officer.

BoardroomKarolinska DevelopmentPharmaceutical

Gilead announces three promotions in senior management team

Gilead announces three promotions in senior management team

28-01-2014

US biotech major Gilead Sciences (Nasdaq: GILD) has announced several promotions within the company's…

BiotechnologyBoardroomGilead SciencesUSA

Chelsea Therapeutics names Joseph Oliveto as president and CEO

Chelsea Therapeutics names Joseph Oliveto as president and CEO

27-01-2014

US biotech firm Chelsea Therapeutics’ (Nasdaq: CHTP) has named Joseph Oliveto as president and chief…

BiotechnologyBoardroomChelsea TherapeuticsUSA

Purdue Pharma names Mark Timney president and CEO

27-01-2014

Privately-held US drugmaker Purdue Pharma has appointed Mark Timney as president and chief executive.…

BoardroomManagementPharmaceuticalPurdue Pharma

Merck KGaA’s CFO Matthias Zachert joins Lanxess as CEO

Merck KGaA’s CFO Matthias Zachert joins Lanxess as CEO

27-01-2014

Chief financial officer of Germany’s Merck KGaA (MRK: DE) Matthias Zachert has been appointed as chief…

BoardroomLanxessMerck KGaAPharmaceutical

Susan Kilsby to succeed Matthew Emmens as chairman of Shire

Susan Kilsby to succeed Matthew Emmens as chairman of Shire

23-01-2014

Ireland-headquartered drugmaker Shire (LSE: SHP) has announced that Susan Kilsby will become non-executive…

BoardroomEuropePharmaceuticalShire

Ipsen implements new US governance to prepare for Somatuline launch in oncology

Ipsen implements new US governance to prepare for Somatuline launch in oncology

22-01-2014

French drugmaker Ipsen (Euronext: IPN) has announced new governance in the USA following its decision…

BoardroomIpsenOncologyPharmaceuticalSomatulineUSA

Swedish company Dilaforette announces Sobi’s Christina Herder as new CEO

22-01-2014

Swedish drug development company Dilaforette has named Christina Herder as its new chief executive.

BoardroomDilaforetteHematologyNorthern EuropePharmaceuticalSobi

28 to 52 of 100 results

Back to top